Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions

NCT01981759 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT01981759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01981759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
Lead sponsor
NYU Langone Health
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2014
Completion date
October 31, 2017
Enrollment
58 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

delusional disorder, schizoaffective disorder, schizophrenia